← Back to headlines
Relmada Therapeutics Plans Mid-2026 Phase 3 RESCUE Trial Start
Relmada Therapeutics announced plans to initiate its Phase 3 RESCUE trial in mid-2026, supported by a cash runway of $234 million projected to last through 2029.
13 May, 01:31 — 13 May, 01:31
Sources
Showing 1 of 1 sources
